Vivimed W/O Sunscreen Formulation Formula Ref. 2-016-18

Vivimed Labs Ltd
Phase
Product
INCI Name
Supplier
Volume
A
Arlacel 1690
Sorbitan Isostearate (and) Polyglyceryl-3 Polyricinoleate
Croda
3.50
Span 83
Sorbitan Sesquioleate
Croda
1.00
Arlamol HD
Isohexadecane
Croda
3.00
Tegosoft XC
Phenoxyethyl Caprylate
Evonik
5.00
Finsolv EB
Ethylhexyl Benzoate
Innospec
10.00
Candelilla Wax
Candelilla Cera
Various
0.50
OMC
Ethyl Hexyl Methoxycinnamate
Various
4.00
Avis
Butyl Methoxydibenzoylmethane
Vivimed
4.00
Etone
Ethylhexyl Triazone
Vivimed
2.00
Titriplex III
Disodium EDTA
Merck
0.10
RonaCare AP
Bis-ethylhexyl Hydroxydimethoxy Benzylmalonate
Merck
1.00
B
Bentone Gel IHD-V
Isohexadecane (and) Disteardimonium Hectorite (and) Propylene Carbonate
Elementis
3.00
C
Deionised Water
Aqua
48.20
Pricerine 9091
Glycerine
Croda
3.00
MgSO4.7H2O
Magnesium Sulphate Heptahydrate
Various
0.70
Vivsonic
Phenylbenzimidazole Sulfonic Acid
Vivimed
2.00
Triethanolamine 90%
Triethanolamine
Various
1.2
D
Solaveil XT-100
Titanium Dioxide (and) C12-15 Alkyl Benzoate (and) Polyhydroxystearic Acid (and) Stearic Acid (and) Alumina
Croda
7.00
E
Euxyl PE9010
Phenoxyethanol (and) Ethylhexylglycerin
Clariant
0.80

Preparation:

1. Combine phase A and heat to 80-85oC. 2. When fully molten and homogenous, add phase B and homogenise. Re-heat to 75-80oC. 3. Prepare phase C and heat to 75-80°C. 4. Add C to A/B slowly with intensive stirring. Homogenise for 2 mins per 100g. 5. Add D with stirring. Homogenise for 1 min. 6. Cool with intensive stirring to 50oC. 7. Add phase E below 50oC. Continue to cool with stirring to room temp.

Notes:

Test Data: 8240cps / in-vitro SPF53 / UVA:UVB ratio 0.746
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

Esperis SpA

Esperis S.p.A. founded in 1922 (Milan) is a leading company in the development, production, and distribution of cosmetic, perfumery and pharmaceutical ingredients. Our product portfolio is rich, varied and deals with high-quality raw materials, suitable for the formulation of skin care, hair care and personal care products.
Esperis S.p.A....

Learn more »

in-cosmetics Global 2025

RAI Amsterdam
8th - 10th April 2025

CITE JAPAN 2025

Pacifico Yokohama
14th - 16th May 2025